Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeffrey Sawyer

Concepts (180)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Chromosomes, Human, Pair 1
8
2019
96
2.220
Why?
Multiple Myeloma
21
2024
3049
1.510
Why?
Scoliosis
5
2024
62
1.500
Why?
Translocation, Genetic
6
2019
265
1.300
Why?
Slipped Capital Femoral Epiphyses
2
2025
9
1.130
Why?
Orthopedic Procedures
2
2025
71
1.070
Why?
Orthopedics
3
2022
53
1.040
Why?
Bone Screws
1
2025
30
0.940
Why?
Ambulatory Surgical Procedures
1
2025
52
0.910
Why?
Fractures, Open
1
2022
8
0.760
Why?
Methicillin-Resistant Staphylococcus aureus
1
2022
82
0.700
Why?
Diagnostic Imaging
1
2021
181
0.650
Why?
Chromosomal Instability
1
2019
16
0.640
Why?
Staphylococcal Infections
1
2022
285
0.600
Why?
Pediatrics
1
2021
293
0.570
Why?
Child
12
2025
7248
0.510
Why?
Gene Amplification
2
2019
58
0.480
Why?
Transplantation, Autologous
3
2024
488
0.480
Why?
Heterochromatin
2
2009
4
0.470
Why?
Gene Dosage
1
2015
78
0.470
Why?
Chromosome Deletion
2
2017
142
0.450
Why?
Chromosomes, Human, Pair 17
1
2014
35
0.430
Why?
Humans
36
2025
52483
0.410
Why?
Melphalan
2
2016
181
0.390
Why?
Chromosome Aberrations
5
2016
297
0.370
Why?
Myelodysplastic Syndromes
2
2013
86
0.370
Why?
In Situ Hybridization, Fluorescence
4
2019
263
0.340
Why?
Follow-Up Studies
6
2024
2279
0.310
Why?
Retrospective Studies
7
2025
6607
0.290
Why?
Adolescent
6
2025
6739
0.290
Why?
Hematopoietic Stem Cell Transplantation
2
2024
603
0.280
Why?
Tomography, X-Ray Computed
2
2025
1165
0.280
Why?
Prognosis
8
2021
2099
0.280
Why?
Myeloablative Agonists
1
2007
32
0.280
Why?
Hematopoietic Stem Cell Mobilization
1
2007
60
0.280
Why?
Age of Onset
2
2024
110
0.270
Why?
Spinal Fusion
2
2024
72
0.250
Why?
Spondylolysis
1
2025
2
0.240
Why?
Male
14
2025
26761
0.230
Why?
Female
15
2025
28171
0.230
Why?
Disease Progression
3
2019
871
0.230
Why?
Firearms
1
2024
19
0.220
Why?
Lumbar Vertebrae
1
2025
104
0.220
Why?
Bone Marrow
3
2022
364
0.220
Why?
Perioperative Care
1
2024
43
0.220
Why?
Wounds, Gunshot
1
2024
33
0.220
Why?
Cost of Illness
1
2024
121
0.210
Why?
Neoplasms, Second Primary
1
2024
77
0.210
Why?
Postoperative Care
1
2024
104
0.210
Why?
Neoplasm, Residual
2
2022
173
0.210
Why?
Child, Preschool
4
2025
4076
0.210
Why?
Inpatients
1
2025
205
0.210
Why?
Cytogenetic Analysis
2
2014
80
0.200
Why?
Reoperation
1
2025
465
0.200
Why?
Clubfoot
1
2022
2
0.190
Why?
Foot Orthoses
1
2022
7
0.190
Why?
Mutation
2
2020
1347
0.190
Why?
Radiologic Health
1
2021
2
0.190
Why?
Risk Adjustment
1
2021
16
0.180
Why?
Gene Expression Regulation, Neoplastic
4
2016
857
0.170
Why?
Fasting
1
2020
75
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Treatment Outcome
4
2025
5422
0.170
Why?
Research Design
1
2022
359
0.160
Why?
Proto-Oncogene Proteins B-raf
1
2020
81
0.160
Why?
Karyotyping
3
2017
78
0.150
Why?
Syndrome
1
2019
247
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1031
0.150
Why?
Adult
7
2024
14161
0.150
Why?
Karyotype
2
2017
19
0.150
Why?
Quality of Life
1
2024
879
0.150
Why?
Postoperative Complications
1
2025
1068
0.140
Why?
Chromosome Disorders
1
2017
32
0.140
Why?
Genetic Association Studies
1
2017
122
0.130
Why?
Thalidomide
2
2016
377
0.130
Why?
Gene Expression Profiling
6
2014
1105
0.130
Why?
Young Adult
2
2024
4329
0.120
Why?
Anti-Bacterial Agents
1
2022
807
0.120
Why?
Antibodies, Monoclonal
1
2019
481
0.120
Why?
Aged
9
2024
10121
0.120
Why?
Genome, Human
1
2015
121
0.120
Why?
Alleles
1
2015
276
0.110
Why?
Genetic Predisposition to Disease
1
2017
528
0.110
Why?
Neoplasm Recurrence, Local
2
2022
649
0.110
Why?
Interspersed Repetitive Sequences
1
2014
7
0.110
Why?
Gene Fusion
2
2014
9
0.110
Why?
Chromosomes, Human, Pair 14
1
2014
75
0.110
Why?
Metaphase
2
2016
46
0.100
Why?
Bone Marrow Cells
1
2014
190
0.100
Why?
Risk
1
2014
316
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Consensus
2
2024
181
0.100
Why?
Transcription Factors
1
2015
566
0.090
Why?
Risk Factors
4
2025
3889
0.090
Why?
Epigenesis, Genetic
1
2015
406
0.090
Why?
Observer Variation
2
2022
134
0.090
Why?
Infant
3
2025
3733
0.090
Why?
DNA Methylation
1
2015
592
0.090
Why?
Reproducibility of Results
3
2022
1229
0.080
Why?
Middle Aged
6
2024
13028
0.080
Why?
Survival Rate
3
2020
945
0.080
Why?
Chromosome Breakage
1
2009
16
0.080
Why?
Neoplasms
1
2017
1325
0.070
Why?
Age Distribution
1
2007
174
0.070
Why?
Disease-Free Survival
2
2019
460
0.070
Why?
Prospective Studies
2
2016
2481
0.070
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Models, Genetic
1
2006
169
0.060
Why?
Kaplan-Meier Estimate
1
2007
483
0.060
Why?
Paraproteinemias
1
2006
74
0.060
Why?
Leukemia, Myeloid, Acute
1
2007
203
0.060
Why?
Cyclin D1
1
2005
57
0.060
Why?
Predictive Value of Tests
1
2007
944
0.060
Why?
Databases, Factual
1
2007
706
0.060
Why?
Delphi Technique
1
2024
63
0.060
Why?
Travel
1
2024
37
0.060
Why?
Survival Analysis
2
2021
673
0.050
Why?
Morphine
1
2023
105
0.050
Why?
Braces
1
2022
9
0.050
Why?
Analgesics
1
2023
107
0.050
Why?
Pain, Postoperative
1
2023
169
0.050
Why?
Prevalence
1
2025
1006
0.050
Why?
Dexamethasone
1
2024
438
0.050
Why?
Arkansas
1
2007
2028
0.050
Why?
Epiphyses
1
2021
6
0.050
Why?
Practice Guidelines as Topic
1
2024
488
0.040
Why?
Hunger
1
2020
15
0.040
Why?
Conscious Sedation
1
2020
18
0.040
Why?
Lower Extremity
1
2022
100
0.040
Why?
Evidence-Based Medicine
1
2022
261
0.040
Why?
Patient Compliance
1
2022
230
0.040
Why?
Radiography
1
2021
470
0.040
Why?
Phenotype
2
2017
789
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Centromere
1
1998
13
0.040
Why?
Chromosomes, Human, Pair 22
1
2017
39
0.040
Why?
Time Factors
1
2024
2968
0.040
Why?
Genetic Testing
1
2017
129
0.030
Why?
Emergency Service, Hospital
1
2020
522
0.030
Why?
Chromosome Mapping
2
2006
154
0.030
Why?
Electroencephalography
1
2017
312
0.030
Why?
Cyclins
2
2006
38
0.030
Why?
Hepatocyte Growth Factor
1
2015
11
0.030
Why?
Risk Assessment
1
2019
1327
0.030
Why?
Binding Sites
1
2015
377
0.030
Why?
Neoplasm Proteins
1
2016
334
0.030
Why?
United States
1
2024
5192
0.030
Why?
Promoter Regions, Genetic
1
2015
467
0.030
Why?
Polymorphism, Single Nucleotide
1
2015
505
0.020
Why?
Boronic Acids
1
2013
183
0.020
Why?
Comparative Genomic Hybridization
1
2012
39
0.020
Why?
Pyrazines
1
2013
190
0.020
Why?
Microarray Analysis
1
2012
71
0.020
Why?
Acute Disease
1
2013
373
0.020
Why?
RNA, Messenger
2
2006
1132
0.020
Why?
Biopsy, Needle
1
2012
183
0.020
Why?
Cell Line, Tumor
1
2015
1470
0.020
Why?
Models, Statistical
1
2012
230
0.020
Why?
Magnetic Resonance Imaging
1
2017
1546
0.020
Why?
Incidence
1
2013
1062
0.020
Why?
Sensitivity and Specificity
1
2012
891
0.020
Why?
Case-Control Studies
1
2012
1201
0.020
Why?
Multigene Family
1
2006
48
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Syndecan-1
1
2006
74
0.020
Why?
Proteoglycans
1
2006
87
0.020
Why?
Cluster Analysis
1
2006
233
0.020
Why?
Data Interpretation, Statistical
1
2006
164
0.020
Why?
Cyclin D3
1
2005
5
0.010
Why?
Cyclin D2
1
2005
21
0.010
Why?
Trisomy
1
2005
35
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2006
405
0.010
Why?
Membrane Glycoproteins
1
2006
244
0.010
Why?
Recurrence
1
2006
672
0.010
Why?
Proportional Hazards Models
1
2006
443
0.010
Why?
Plasma Cells
1
2006
239
0.010
Why?
Bone Diseases
1
2005
96
0.010
Why?
Cohort Studies
1
2006
1542
0.010
Why?
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description